Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Sky's the Limit for Avanir Pharmaceuticals
Seeking Alpha
Monday, June 28, 2010 - 2:56pm
tags:
Avanir, Zenvia
Orexigen says obesity drug treated depression
Yahoo/AP
Monday, June 28, 2010 - 2:55pm
tags:
Orexigen, obesity, depression, Contrave
Biodel, Arena Pharma: Volume Movers
TheStreet.com
Monday, June 28, 2010 - 2:54pm
tags:
Biodel, Arena Pharmaceuticals, diabetes, obesity
Mannkind Falls Following Afrezza Presentation; Hapoalim Reiterates Sell
Barron's
Monday, June 28, 2010 - 2:53pm
tags:
MannKind, Afrezza, diabetes, inhaled insulin, Hapoalim
Novartis needs Alcon directors' OK for buyout -advisor
Reuters
Monday, June 28, 2010 - 1:45pm
tags:
Alcon, M&A, Novartis
Avandia, Heart Attacks & An Upcoming FDA Meeting
Pharmalot
Monday, June 28, 2010 - 1:43pm
tags:
Avandia, heart attacks, GSK, diabetes, FDA, Actos, Takeda
Data shows declining productivity in drug R&D
Reuters
Monday, June 28, 2010 - 1:42pm
tags:
R&D, drug development
Good News for Shire
Yahoo/Zacks.com
Monday, June 28, 2010 - 1:39pm
tags:
Shire, Pfizer, Protalix BioTherapeutics, Vpriv, Gaucher disease
Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
Yahoo
Monday, June 28, 2010 - 1:36pm
tags:
Eli Lilly, Marcadia, hypoglycemia, partnerships, glucagon
Doc Who Faked Pfizer Studies Gets 6 Months in Prison, Showing Why Gift Bans Are a Good Idea
BNET Pharma
Monday, June 28, 2010 - 1:31pm
tags:
physician gifts, Pfizer
Astellas Pharma, Teva Reach Settlement Over Incontinence Medicine Vesicare
Bloomberg
Monday, June 28, 2010 - 9:58am
tags:
Astellas, Teva Pharmaceuticals, settlements, Vesicare, urinary incontinence
J&J Subsidiary Joins the Diabetes Fray
Seeking Alpha
Monday, June 28, 2010 - 9:56am
tags:
diabetes, JNJ, Ortho-McNeil-Janssen, Metabolex, Diamyd Medical
5 Reasons Why Amarin Is My Top Buy
Seeking Alpha
Sunday, June 27, 2010 - 11:23am
tags:
Amarin, Epadel, GSK, Lovaza, omega-3 fatty acid, AMR101
Editorials: In praise of an unsinkable biotech business
Mlive
Sunday, June 27, 2010 - 11:18am
tags:
Esperion Therapeutics, HDL therapy
In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantly Greater Blood Sugar Lowering Compared with Pioglitazone
Yahoo/BusinessWire
Sunday, June 27, 2010 - 11:07am
tags:
Januvia, Merck, pioglitazone, diabetes, type 2 diabetes, Actos, Takeda
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Seeking Alpha
Sunday, June 27, 2010 - 11:04am
tags:
Anthera, A-002, acute coronary syndrome, GSK, darapladib
China Biotech Week in Review
Seeking Alpha
Sunday, June 27, 2010 - 11:02am
tags:
China, biotech
Preclinical Results With XOMA 052 in Type 2 Diabetes Presented at American Diabetes Association 70th Scientific Sessions
Yahoo/Globe NewsWire
Sunday, June 27, 2010 - 10:59am
tags:
XOMA 052, Xoma, diabetes, type 2 diabetes
Improvement in Beta-Cell Function Observed After Three Years of BYETTA(R) Therapy: Data Presented at ADA 2010
Yahoo/PR NewsWire
Sunday, June 27, 2010 - 10:56am
tags:
Eli Lilly, Amylin, Byetta, diabetes, type 1 diabetes
Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
Yahoo/PR NewsWire
Sunday, June 27, 2010 - 10:54am
tags:
Symlin, Amylin, diabetes, type 1 diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.